Remicade (infliximab) infusion price isn’t fixed. It depends on where you are, your dose, the number of vials needed, the infusion center’s fees, and your insurance or patient assistance. Here’s how to think about it in the U.S.:
- Dose depends on weight and condition. For Crohn’s disease or ulcerative colitis, typical induction is 5 mg/kg at weeks 0, 2, and 6, then every 8 weeks. For a 70 kg adult, that’s about 350 mg per infusion.
- Vial size and drug cost. Remicade is given in vials (commonly 100 mg per vial). So 350 mg would require about 4 vials (and possibly some waste). List prices for the drug alone per 100 mg vial have historically ranged roughly from $1,000 to $2,000 or more, depending on year and payer.
- Infusion center/admin fees. On top of the drug, you’ll have facility/administration fees, which can be several hundred dollars per infusion.
- Rough ballpark (before insurance): drug cost ≈ $4,000–$8,000 plus $300–$700 infusion fees, so total ≈ $4,300–$8,700 per infusion, depending on exact vial price and fees.
- Biosimilars can be cheaper. Inflectra and Renflexis are available and may cost less than Remicade—often by a noticeable margin, varying by plan.
- With insurance or patient assistance, out-of-pocket costs can be much lower, sometimes significantly so.
If you share:
- your country,
- your weight,
- the exact dose you’re being told to receive (mg/kg and schedule),
- whether you have insurance (and the type of plan),
I can help estimate a more tailored cost. I can also help you compare Remicade vs. a biosimilar and point you to potential patient financial-assistance options.